|
1
|
Corpus CU and Vulva UOV: Gynecologic
Cancer Incidence, United States-2012-2016; Centers for Disease
Control and Prevention, US Department of Health and Human Services:
Atlanta, GA, USA, 2019.
|
|
2
|
Dellino M, Cascardi E, Laganà AS, Di Vagno
G, Malvasi A, Zaccaro R, Maggipinto K, Cazzato G, Scacco S, Tinelli
R, et al: Lactobacillus crispatus M247 oral administration: Is it
really an effective strategy in the management of
papillomavirus-infected women? Infect Agent Cancer.
17(53)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Viviani S, Dellino M, Ramadan S, Peracchio
C, Marcheselli L, Minoia C and Guarini A: Fertility preservation
strategies for patients with lymphoma: A real-world practice survey
among Fondazione Italiana Linfomi centers. Tumori. 108:572–577.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen Q, Zhou L, Ma D, Hou J, Lin Y, Wu J
and Tao M: LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis
of colorectal cancer by regulating TRIM14 through
miR-370-3p/miR-1296-5p and FUS. J Transl Med.
20(356)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A Long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tan DSW, Chong FT, Leong HS, Toh SY, Lau
DP, Kwang XL, Zhang X, Sundaram GM, Tan GS, Chang MM, et al: Long
noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor
addiction and modulates treatment response in squamous cell
carcinoma. Nat Med. 23:1167–1175. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Xu Y, Ge Z, Zhang E, Zuo Q, Huang S, Yang
N, Wu D, Zhang Y, Chen Y, Xu H, et al: The lncRNA TUG1 modulates
proliferation in trophoblast cells via epigenetic suppression of
RND3. Cell Death Dis. 8:e3104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lin H, Xu X, Chen K, Fu Z, Wang S, Chen Y,
Zhang H, Niu Y, Chen H, Yu H, et al: LncRNA CASC15, MiR-23b cluster
and SMAD3 form a novel positive feedback loop to promote
epithelial-mesenchymal transition and metastasis in ovarian cancer.
Int J Biol Sci. 18:1989–2002. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cao HL, Liu ZJ, Huang PL, Yue YL and Xi
JN: lncRNA-RMRP promotes proliferation, migration and invasion of
bladder cancer via miR-206. Eur Rev Med Pharmacol Sci.
23:1012–1021. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kong X, Duan Y, Sang Y, Li Y, Zhang H,
Liang Y, Liu Y, Zhang N and Yang Q: LncRNA-CDC6 promotes breast
cancer progression and function as ceRNA to target CDC6 by sponging
microRNA-215. J Cell Physiol. 234:9105–9117. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xiao Z, Liu Y, Zhao J, Li L, Hu L, Lu Q,
Zeng Z, Liu X, Huang D, Yang W and Xu Q: Long noncoding RNA
LINC01123 promotes the proliferation and invasion of hepatocellular
carcinoma cells by modulating the miR-34a-5p/TUFT1 axis. Int J Biol
Sci. 16:2296–2305. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vrba L, Garbe JC, Stampfer MR and Futscher
BW: A lincRNA connected to cell mortality and
epigenetically-silenced in most common human cancers. Epigenetics.
10:1074–1083. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen X, Huang Y, Shi D, Nie C, Luo Y, Guo
L, Zou Y and Xie C: LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by
Adsorbing microRNA-1290 to Suppress Nasopharyngeal Carcinoma Cell
Progression. Onco Targets Ther. 13:4397–4409. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang H, Cai MY, Rong H, Ma LR and Xu YL:
ZNF667-AS1, a positively regulating MEGF10, inhibits the
progression of uveal melanoma by modulating cellular
aggressiveness. J Biochem Mol Toxicol. 35(e22732)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang D, Wang Y, Zou X, Shi Y, Liu Q, Huyan
T, Su J, Wang Q, Zhang F, Li X and Tie L: FOXO1 inhibition prevents
renal ischemia-reperfusion injury via cAMP-response element binding
protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis. Br
J Pharmacol. 177:432–448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Feng Y, Zhang Z, Yang H, Miao F, Li Y,
Zhang M, Cao Y and Li M: The lncRNA TPTEP1 suppresses PI3K/AKT
signalling and inhibits ovarian cancer progression by interacting
with PTBP1. J Cell Mol Med. 28(e70106)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang Z, Senocak F, Jayaraman A and Hahn
J: Integrated modeling and experimental approach for determining
transcription factor profiles from fluorescent reporter data. BMC
Syst Biol. 2(64)2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cervena K, Vodenkova S and Vymetalkova V:
MALAT1 in colorectal cancer: Its implication as a diagnostic,
prognostic and predictive biomarker. Gene.
843(146791)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the Notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7(13616)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Huang Y, Zhang J, Hou L, Wang G, Liu H,
Zhang R, Chen X and Zhu J: LncRNA AK023391 promotes tumorigenesis
and invasion of gastric cancer through activation of the PI3K/Akt
signaling pathway. J Exp Clin Cancer Res. 36(194)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao LP, Li RH, Han DM, Zhang XQ, Nian GX,
Wu MX, Feng Y, Zhang L and Sun ZG: Independent prognostic Factor of
low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory
function on the proliferation of cervical cancer. Eur Rev Med
Pharmacol Sci. 21:5353–5360. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Vrba L and Futscher BW: Epigenetic
silencing of MORT is an early event in cancer and is associated
with luminal, receptor positive breast tumor subtypes. J Br Cancer.
20(198)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vrba L and Futscher BW: Epigenetic
silencing of lncRNA MORT in 16 TCGA cancer types. F1000Research.
7(211)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu M, Yi Y and Zhao M: Effect of
dexmedetomidine anesthesia on perioperative levels of TNF-α and
IL-6 in patients with ovarian cancer. Oncol Lett. 17:5517–5522.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gupta M, Babic A, Beck AH and Terry K:
TNF-α expression, risk factors and inflammatory exposures in
ovarian cancer: Evidence for an inflammatory pathway of ovarian
carcinogenesis? Hum Pathol. 54:82–91. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Felices M, Chu S, Kodal B, Bendzick L,
Ryan C, Lenvik AJ, Boylan KLM, Wong HC, Skubitz APN, Miller JS and
Geller MA: IL-15 super-agonist (ALT-803) enhances natural killer
(NK) cell function against ovarian cancer. Gynecol Oncol.
145:453–456. 2017.PubMed/NCBI View Article : Google Scholar
|
